, , , , , , ,

User Fees for Medical Devices: Third Time Lucky?

John R. Graham, Director, Health Care Studies

Congress recently passed, almost unanimously, S.3187, the Food and Drug Administration Safety and Innovation Act. Title II of the Act comprised the third reauthorization of user fees for the medicaldevice industry, for fiscal years 2013 through 2017.

A product of lengthy negotiations between the medical-device industry and the Food and Drug Administration, the amendments commit the FDA to a number of new performance goals.

Read the full report here: www.pacificresearch.org/docLib/20120702_HPPJune.2012_F.pdf.

About these ads